DOCSF 2023: Epigenomics
Explore the realm of epigenomics through the insights of Dr. Stefano Bini’s interview with Madalena Adorno, CEO of Dorian Therapeutics. Uncover Adorno’s pioneering research on stem cells and aging biology, shedding light on the intricate interplay between senescent and stem cells in the context of aging and conditions like osteoarthritis. She also delves into her breakthrough studies on Down syndrome, revealing the identification of a key gene driving the aging phenotype.
Tune in to learn how Dorian Therapeutics is pioneering a small molecule approach to USP 16 inhibition, offering promising avenues in the field of aging research.